Elekta Research and global business development. Sören Johansson, Vice President, Business development

Transkript

1 Elekta Research and global business development Sören Johansson, Vice President, Business development

2 Ett historiskt perspektiv - från Innovation till Industri Hjärt-lungmaskiner Strålkniven Radioterapi Dialysutrustningen AGA Elekta Gambro Ett resultat av ett nära samarbete mellan industri, akademi och sjukvården Titanimplantat Nobel Biocare Hörselimplantat Mikromekanisk trycksensor Entific / Cochlear Radi Medical / St Jude

3 Ett historiskt perspektiv - från Innovation till Industri Pacemakern Siemens Elema / St Jude Operation och sårbehandling Mölnlycke Health Care Infektionskontroll, kirurgi och intensivvård Getinge Implantat, urologi, kirurgi och andningshjälpmedel Astra Tech Digital röntgen IT lösningar i sjukvården Sectra Cambio

4 Elekta one of the fastest growing companies in radiation therapy Every year over 1,000,000 patients benefit from treatment with radiation therapy equipment from Elekta One of the fastest growing companies in the radiation therapy field Close to 3,400 employees worldwide* Net sales SEK 9.0 bn, operating result SEK 1.8 bn, margin 20% Headquarters in Stockholm, Sweden offices in about 40 countries * Incl. acquisition of Nucletron

5 Strong growth with increased profitability SEK M Net Sales SEK M EBIT

6 Cancer incidence is growing Cancer incidence Million ,4 19,1 16, ,0 13,3 12, E 2020E 2025E 2030E Lung Breast Colorectum Stomach Prostate Liver Cervix uteri Oesophagus Bladder Non-Hodgkin Leukaemia Most frequent cancers 1,6 1,4 1,2 1,0 0,9 0,7 0,5 0,5 0,4 0,4 0,4 0,0 0,5 1,0 1,5 2010A World population: 7.0 bn Population +60 years, world: 760 M Age group +60 years will grow at the highest pace +20% +82% 2030E 8.3 bn 1.4 bn Approx. 60 percent* of all new cancer cases occur in age group +60 years Number of new cancer cases per year (millions, 2008) Source: Globocan 2008

7 Från innovation till generisk utveckling Gamma Knife surgery Stereotactic Radiation Therapy Medicinteknik är applied science ; nya upptäckter inte nödvädigt för att utveckla nya och viktiga lösningar Generisk FoU Volumetric Modulated Arc therapy Image Guided Radiation Therapy Precision Radiation Therapy

8 Measurements From treatment and system to disease management Analysis Information Today & tomorrow Complex solutions Clinical solutions Organisational impact Internationalization High commercialisation costs The old days Simple solutions Direct to end-user Not so expensive to commercialise Knowledge Wisdom

9 Technology as a facilitator for a changing practice Todays objectives Maximize dose to tumor Avoid adjacent critical structures High quality, efficient delivery 1. Solutions for effective radiotherapy 2. Workflow 3. Efficiency 4. Simplicity

10 Evolution of Elekta s role in cancer care Comprehensive solutions Technology IMRT IGRT Solutions Agility TM VMAT MOSAIQ RTP Flexitron solution Disease pathways Elekta Lung Research Group Elekta Clarity consortium Elekta Spine consortium Leksell Gamma Knife Society Disease management Full offering Data management - informatics More service and upgrades

11 Emerging markets Leadership and strong growth 2004/ / /15E 20% 80% 30% 70% 40% 60% Emerging markets Mature markets Invest ahead of the curve Focus on training and education Product development specialized for emerging markets *Net sales, rounded figures

12 Elekta has strong performance in emerging markets Elekta emerging markets Net sales, SEK bn CAGR 26% * 1,9 2,2 2,6 No. 1 No. 1 1,3 No. 1 08/09 09/10 10/11 11/12 No.1 (shared) *Excl. Nucletron CAGR is 22%

13 Innovation through collaboration

14 Collaboration with leading clinical centers Centers of Excellence Key Princess Margaret Hospital, Toronto IGRT Clinical Program KS, Stockholm SRS R&D and Clinical Training Clinical Residency Training (Eur) NKI-AVL, Amsterdam IGRT/4D Clinical Program UMC, Utrecht IGRT Clinical Program Wurzburg University Clinic SRT Clinical Program BNI Beijing Western China Univ Huaxi SPI/Swedish Hospital, Seattle IGRT/VMAT Clinical Program Mannheim University Clinic IMRT / VMAT Clinical Program EMR / MOP Clinical Program Tokyo University Hospital UPMC, Pittsburgh SRS William Beumont Hospital, Detroit Partners in R&D Workflow Clinical publications Financial feasibility Risk assessment Regulatory demand

15 Sverige som bas för en medicinteknisk företagsutveckling 1. Det svenska sjukvårdssystemet har en bra vision, det krävs dock en kontinuerlig klinisk utveckling inom sjukvården för att bibehålla ledarskap 2. Det finns ett behov att balansera pragmatisk leverans av vård med forskning och klinisk utveckling för att utveckla patientvården 3. Vår sjukvårdsfinansiering har skapat felaktiga drivkrafter på avdelningsnivå - budgetsystem kontrollerar kostnader utan att belöna förbättrad outcome 4. Svaghet i beslutsfattande och auktoritet vid implementering av förändringar inom sjukvårdsorganisationen 5. Sjukvården i Sverige saknar insikten att industrin är en viktig partner till dem i arbetet att utveckla densamma 6. Industrin är ej en passiv intressent.

16 Förutsättningar för samverkan industrisjukvård Attityd Transparens samt öppenhet att se industrin som en partner i arbetet att utveckla sjukvården Skapa en gemensam vision av ett partnerskap där industrin samt sjukvården samarbetar för att utveckla en kostnadseffektiv sjukvård

17 Förutsättningar för samverkan industrisjukvård Budget och organisation Sjukvården bör skapa ekonomiskt samt organisatoriskt utrymme som möjliggör samverkan med industrin samt tydliga ledningsformer och spelregler Förändrad syn på hur upphandlingsregler tillämpas i samverkansprojekt och innovationsupphandling

18 Elekta R&D in Sweden - conditions for collaboration with academia in Sweden Strong internal R&D in Sweden 150% organic growth since the year 2000 Now around 80 engineers in Stockholm, working in close collaboration with other Elekta R&D centers globally Recent addition of 35 engineers in Uppsala (Nucletron acquisition) Swedish R&D is internationally competitive Excellent supply of competence Example: Recent recruitment of one Research Engineer to Elekta Stockholm resulted in 100+ qualified applicants, out of which more than 40 had Ph.D. degrees Several Swedish universities have started Master programs in Medical Engineering Creativity and problem-solving mindset Straight communication and transparency Reasonable cost structure

19 Elekta Research & Development Sites St Louis Sunnyvale (Information systems) Montreal (US imaging) (Treatment planning) Stockholm (Neuro) Crawley (Oncology) Atlanta (Treatment planning) Uppsala (Brachy, RTP) Milano (Oncology) Helsinki (Neuro) Veenendaal (Brachy) Schwabmünchen (Oncology) Beijing (Oncology) Shanghai (RTP/Neuro) Product development driven by customer needs, in close collaboration with leading centers worldwide June 2012

20 Research collaboration with hospitals Industry perspective Elekta has many active clinical and technical collaborations with hospitals and universities around the world, but most large projects are outside Sweden Access to clinical expertise is a key success factor for developing innovative products From the industry perspective, an ideal partner has: Established scientific leadership in the relevant area Access to additional funding (hospital, regional, national, international) A shared vision and passion to create innovative and cost efficient healthcare solutions Geographical proximity helps but is not a requirement

21 Ongoing research collaborations in Sweden Swedish partners Linköping University, Lund University, Linköping University Hospital Karolinska Hospital Project Fluorescence spectroscopy for neurosurgery Narrow beam dosimetry and Monte Carlo simulations Leksell Gamma Knife treatment planning (M.Sc. project) Stereotactic radiotherapy Chalmers University of Technology (VINN Excellence Centre Chase) Chalmers University of Technology (EU project with 13 partners) Hyperthermia for head and neck cancer Hybrid MEG-MRI Imaging System Uppsala University Hospital CTMH, Stockholm CMIV, Linköping Radiotherapy planning Clinical Innovation Fellowship, Team Onkologi industridoktorandbidrag?? VR, Avancerade MR-metoder för funktionell och stereotaktisk neurokirurgi

22 1. Nyföretagande vs utveckling av etablerat företag 2. Nya innovationer vs Vidareutveckling av befintliga produkter 3. Akademisamarbeten vs Kliniksamarbeten 4. Akademi och Industri har samma behov och mål Ledarskap Excellence Competence Behov av samverkan (Industri akademi) Tillgång till sjukvård och klinik